Nanotechnology Now - Press Release: Grapheal raises EUR1.9 million to advance development of embedded biosensing technology and application in digital COVID testing and wound monitoring: Includes seed financing from Novalis Biotech and private investors, support from Bpifrance as well as non-dilutive grants

Date 11th, Feb 2021
Source Nanotechnology Now - Nanotechnology Websites

DESCRIPTION

Grapheal, a developer of graphene-based embedded biosensors for on-site diagnostics and remote patient monitoring, announced today that it has raised a total of EUR1.9 million in equity and non-diluti...